Equities Turn South, EUR And USD Slide

 | Apr 24, 2020 03:31AM ET

Risk appetite eased yesterday as Gilead's (NASDAQ:GILD) potential medicine for the coronavirus failed its first randomized clinical test. In the currency world, the euro was among the main losers, as the Euro-area PMIs slid more than anticipated. The UK and U.S. preliminary PMI also missed their estimates, suggesting that the global economic outlook continued to deteriorate at the beginning of the second quarter of the year.

Risk Appetite Eases As Gilead's Drug Fails Test

The dollar traded lower against most of the other G10 currencies on Thursday and during the Asian morning Friday. It underperformed the most against NOK, NZD, AUD and CAD in that order, while it lost the least ground against JPY. The greenback eked out gains only versus CHF and EUR.